Optiver Holding
KYMR icon

Optiver Holding’s Kymera Therapeutics KYMR Stock Holding History

Optiver Holding’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.1K Buy
297
+89
+43% +$7.65K ﹤0.01% 1289
2026
Q1 		$17.3K Sell
208
-28
-12% -$2.22K ﹤0.01% 1125
2025
Q4 		$18.4K Sell
236
-86
-27% -$5.81K ﹤0.01% 1039
2025
Q3 		$18.2K Buy
+322
New +$14.5K ﹤0.01% 996

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Optiver Holding's KYMR Position: Q2 2026 in Review

Optiver Holding increased its Kymera Therapeutics (KYMR) stake by 43% in Q2 2026, buying an estimated $7.65K and bringing the position to 297 shares worth $34.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

Optiver Holding first reported a position in KYMR in Q3 2025 and has held it in 4 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Optiver Holding held 297 shares of Kymera Therapeutics worth $34.1K as of Q2 2026.
  • Optiver Holding bought 89 Kymera Therapeutics shares in Q2 2026, an estimated $7.65K.
  • Kymera Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1289 holding.
  • Optiver Holding first reported a position in Kymera Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.